Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with β-lactam-based therapy

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 697-701

  Rao, G Gopal ^a   Mahankali Rao, C S ^a   Starke, I ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

Clostridium difficile associated diarrhoea (CDAD); Levofloxacin

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHI-SQUARE DISTRIBUTION; CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; DIARRHEA; FEMALE; HUMANS; MALE; OFLOXACIN; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 0037339195     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg115     Document Type: Article

References (11)

1. McFarland, L. V. & Stamm, W. E. (1986). Review of Clostridium difficile-associated diseases. American Journal of Infection Control 14, 99-109.
2. Kyne, L., Hamel, M. B., Polavaram, R. & Kelly, C. P. (2002). Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases 34, 346-53.
3. McFarland, L. V., Surawicz, C. M. & Stamm, W. E. (1990). Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. Journal of Infectious Diseases 162, 678-84.
4. Bignardi, G. E. (1998). Risk factors for Clostridium difficile infection. Journal of Hospital Infection 40, 1-15.
5. Golledge, C. L., Carson, C. F., O'Neill, G. L., Bowman, R. A. & Riley, T. V. (1992). Ciprofloxacin and Clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy 30, 141-7.
6. British Thoracic Society (BTS). (2001). Guidelines for the management of community acquired pneumonia in adults. Thorax 56, Suppl 4, 1-64.
7. Lode, H. & Allewelt, M. (2002). Role of newer fluoroquinolones in lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 49, 709-12.
8. Bernstein, J. M. (1999). Treatment of community-acquired pneumonia-IDSA guidelines. Infectious Diseases Society of America. Chest 115, 9S-13S.
9. Acar, J. F. (2001). A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. Chemotherapy 47, Suppl. 3, 15-23.
10. Dean, A. G., Dean, J. A., Burton, A. H. & Dicker, R. C. (1991). Epi Info: a general-purpose microcomputer program for public health information systems. American Journal of Preventive Medicine 7, 178-82.
11. Merrett, P. J. (2000). Incidence of C. difficile-associated diarrhoea and degree of environmental contamination in patients being treated for community acquired LRTI. MSc Dissertation, University of Westminster, London, UK.